Enrico Eugenio Verrina

Dr. Enrico Eugenio Verrina


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
BWBradley A. Warady
Bradley A. Warady
SBSevcan Bakkaloglu
Sevcan Bakkaloglu
JNJason Newland
Jason Newland
MCMichelle Cantwell
Michelle Cantwell
EVEnrico Eugenio Verrina
Enrico Eugenio Verrina
FSFranz Schaefer
Franz Schaefer

1 January 2013 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
EWElke Wühl
Elke Wühl
KSKarlijn J. van Stralen
Karlijn J. van Stralen
EVEnrico Eugenio Verrina
Enrico Eugenio Verrina
ABAnna Bjerre
Anna Bjerre
CWChristoph Wanner
Christoph Wanner
FSFranz Schaefer
Franz Schaefer
Summary: Background and objectives: Congenital anomalies of the kidney and urinary tract (CAKUT) are the leading cause of ESRD in children, but the proportion of patients with individual CAKUT entities progressing to ESRD during adulthood and their long-term clinical outcomes are unknown. This study assessed the age at onset of renal replacement therapy (RRT) and patient and renal graft survival in patients with CAKUT across the entire age range. Design, setting, participants, & measurements: Patients with CAKUT were compared with age-matched patients who were undergoing RRT for other renal disorders on the basis of data from the European Renal Association-European Dialysis and Transplant Association Registry. Competing risk and Cox regression analyses were conducted. Results: Of 212,930 patients commencing RRT from 1990 to 2009, 4765 (2.2%) had renal diagnoses consistent with CAKUT. The proportion of incident RRT patients with CAKUT decreased from infancy to childhood and then increased until age 15–19 years, followed by a gradual decline throughout adulthood. Median age at RRT start was 31 years in the CAKUT cohort and 61 years in the non-CAKUT cohort (P<0.001). RRT was started earlier (median, 16 years) in patients with isolated renal dysplasia than in those with renal hypoplasia and associated urinary tract disorders (median, 29.5–39.5 years). Patients with CAKUT survived longer than age- and sex-matched non-CAKUT controls because of lower cardiovascular mortality (10-year survival rate, 76.4% versus 70.7%; P<0.001). Conclusions: CAKUT leads to ESRD more often at adult than pediatric age. Treatment outcomes differ from those of acquired kidney diseases and vary within CAKUT subcategories.

1 July 2014 in Kidney International
Verified
Journal Article
Closed access
KSKariljn J. van Stralen
Kariljn J. van Stralen
DBDagmara Borzych-Dużalka
Dagmara Borzych-Dużalka
HHHiroshi Hataya
Hiroshi Hataya
SKSean E. Kennedy
Sean E. Kennedy
KJKitty J. Jager
Kitty J. Jager
PCPierre Cochat
Pierre Cochat

21 July 2014 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
OROn Behalf Of Theespn/Era–Edta Registry
On Behalf Of Theespn/Era–Edta Registry
NCNicholas Chesnaye
Nicholas Chesnaye
MBMarjolein Bonthuis
Marjolein Bonthuis
FSFranz Schaefer
Franz Schaefer
JGJaap W. Groothoff
Jaap W. Groothoff
KSKarlijn J. Van Stralen
Karlijn J. Van Stralen

1 March 2012 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
JHJérôme Harambat
Jérôme Harambat
KSKarlijn J. van Stralen
Karlijn J. van Stralen
LELaura Espinosa
Laura Espinosa
JGJaap W. Groothoff
Jaap W. Groothoff
SHSally-Anne Hulton
Sally-Anne Hulton
PCPierre Cochat
Pierre Cochat
Summary: Background and objectives: Primary hyperoxaluria (PH) as a cause of ESRD in children is believed to have poor outcomes. Data on management and outcomes of these children remain scarce. Design, setting, participants, & measurements: This study included patients aged <19 years who started renal replacement therapy (RRT) between 1979 and 2009 from 31 countries providing data to a large European registry. Results: Of 9247 incident patients receiving RRT, 100 patients had PH. PH children were significantly younger than non-PH children at the start of RRT. The median age at RRT of PH children decreased from 9.8 years in 1979–1989 to 1.5 years in 2000–2009. Survival was 86%, 79%, and 76% among PH patients at 1, 3, and 5 years after the start of RRT, compared with 97%, 94%, and 92% in non-PH patients, resulting in a three-fold increased risk of death over non-PH patients. PH and non-PH patient survival improved over time. Sixty-eight PH children received a first kidney (n=13) or liver-kidney transplantation (n=55). Although the comparison was hampered by the lower number of kidney transplantations primarily derived from the earlier era of RRT, kidney graft survival in PH patients was 82%, 79%, and 76% at 1, 3, and 5 years for liver-kidney transplantation and 46%, 28%, and 14% at 1, 3, and 5 years for kidney transplantation alone, compared with 95%, 90%, and 85% in non-PH patients. Conclusions: The outcomes of PH children with ESRD are still poorer than in non-PH children but have substantially improved over time.

27 December 2009 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
DTDimitrios J. Tsakiris
Dimitrios J. Tsakiris
VSVianda S. Stel
Vianda S. Stel
PFPatrik Finne
Patrik Finne
EFEmily Fraser
Emily Fraser
JHJames Heaf
James Heaf
KJKitty J. Jager
Kitty J. Jager
Background. Information on demographics and survival of patients starting renal replacement therapy (RRT) for end-stage renal disease (ESRD) due to multiple myeloma (MM) or light-chain deposit disease (LCDD) is scarce. The aim of this study was to describe the incidence, characteristics, causes of death and survival rates of RRT for ESRD due to MM or LCDD in the ERA-EDTA Registry.